Key Takeaways:
- Immundiagnostik is a leading biotech company advancing the medical field with novel immunoassays.
- The company’s innovative diagnostic methods are reshaping outcomes in the biotech and pharmaceutical industries.
- Founded in 1986, Immundiagnostik has a global representation across 30+ countries.
- The future for Immunodiagnostik looks promising with more developments in the pipeline.
Introduction:
Is the revolutionary immunoassay technology reshaping biotech and pharmaceutical outcomes in Europe? The straightforward answer in a word, is yes. There’s one trailblazing company right at the helm of this – Immundiagnostik. Founded in 1986, the German startup has grown into a global entity with its presence across over 30 countries. It is known for its relentless pursuit of cutting-edge technological developments in the realm of immunoassays.
Immuniagnostik specialises in developing and manufacturing innovative immunoassay kits and other analytical detection methods like EIA, ELISA, HPLC and PCR. These methods offer diagnostic laboratories and academic research institutions cutting-edge tools aiding their clinical trials, research and routine medical practices.
Company Differential:
What notably differentiates Immundiagnostik in the biotech landscape is an expansive portfolio of antibodies and antigens, and robust business relations with diagnostic labs, clinical research institutions as well as the pharmaceutical industry. By staying aligned with these entities, the company accelerates product development, facilitating the entry of novel solutions into the market.
A team of over 50 dedicated professionals, and the guidance of founder Franz Paul Armbruster, keeps Immundiagnostik at the forefront of technological and diagnostic advancements. Immundiagnostik’s pipeline of proprietary developments consistently brings innovative and ground-breaking products to the table, inspiring a whole new era of the biotech industry.
Conclusion:
Immundiagnostik is continually building the future of diagnostic technology with a rich pipeline of in-house developments. As they blaze the trail, Immundiagnostik not only shapes the future of their company, but also that of the biotech and pharmaceutical industries, especially in the realm of immunoassays.
Visit the company’s website at www.immundiagnostik.com to find out more. Stay updated by following them on their Twitter, Facebook, and LinkedIn profiles.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
